Navigation Links
Sunrise Reports Preliminary Selected Financial and Operating Data for Fourth-Quarter 2007
Date:3/3/2008

30 million was

restricted for use by the Company's self-insurance program and another

approximately $40 million was restricted for other purposes. The

Company had approximately $250 million in debt outstanding at year-end.

-- There were $100 million in borrowings and $71.7 million in letters of

credit outstanding under the Company's bank credit facility. On

December 31, 2007, the Company had capacity to borrow up to an

additional $78.3 million under this facility.

-- As disclosed previously, on January 31, 2008, the Company amended its

$250 million bank credit facility to waive and modify certain delivery

dates for its financial statements. In addition, effective February

20, 2008, the amount available for borrowing under the bank credit

facility was reduced to $160 million until the Company furnishes the

lender with 2006 and 2007 audited financial statements.

-- On February 20, 2008, Sunrise Senior Living Insurance, Inc., Sunrise's

wholly owned insurance captive, directly issued $43.3 million of

letters of credit that had previously been issued under the bank credit

facility.

-- As of February 29, 2008, the Company had borrowings of $108 million,

letters of credit of $28.4 million and borrowing availability of

approximately $23.6 million under the bank credit facility. The

Company believes this availability, unrestricted cash balances, and

unlevered real estate assets is sufficient to support the Company's

operations over the next twelve months.

Accounting Restatement

-- Sunrise currently estimates that the cumulative impact of the

previously disclosed restatement issues will reduce net income for all

periods impacted, including 1996 through 2005, by approximately $140

million, excluding the impact of the stock option adjustments
'/>"/>

SOURCE Sunrise Senior Living, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Sunrise Announces Release Date for Fourth-Quarter Preliminary Selected Financial and Operating Data
2. Sunrise to Unveil New Residence for Seniors at Clayton on the Park
3. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
4. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
5. Sunrise Senior Living Opens First Custom-Built Community for Early, Mid and Late Stage Alzheimers Care Programs
6. Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007
7. Eclipsys Sunrise Acute Care Receives CCHIT Certification
8. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
9. SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America
10. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
11. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fir...today that a Special Meeting of Shareholders will ...of the Meeting is to consider approval of two spec...o approve and authorize the sale of all or substan... on the terms provided for in the asset purchase a...
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 ... Supermarket Company removed from sale Shedd,s Cou...oli Rice and Shedd,s Country Crock ® Side Dis...sulfite allergen. ,, The following code dates ...k ® Side Dishes DELUXE Cheddar Broccoli Rice ...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswire...sked the U.S. Food and Drug Administration (FDA) t...whitening chemicals. ,, Citing concern about t...inistered without the benefit of professional cons...ion said that the application of chemically based ...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswir...t he is on a mission to redefine what it means to ...essional counselor with a specialty in family coun...t Wake Forest University, Gladding says research s...n leads to sadness and even depression during the ...
(Date:11/20/2009)... An editorial published online November 20 in the...ses the exaggerated fears and hopes that often app...rial provides guidance for both the media and jour...hwartz, M.D., M.S., and Steven Woloshin, M.D., M.S...tmouth Institute for Health Policy and Clinical Pr...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...is drugs causing jaw problems have you wondering: ...at there have been reports of partial death of a j...ications, but the risk is very small, according to...ecome brittle and to fracture — are high. More tha...
...vered that mutations in a gene known as SOS1 accou...n childhood genetic //disorder which occurs in one...y short stature, facial abnormalities, and learnin... for Genetics and Genomics (HPCGG) and Beth Israel...
...more reason why teenage years are perceived as 'tu...the Pandora's Box has opened. //Such teens are pro... their no'vice' contemporaries, a recent insight i...th of data from a 2004 addition survey. The survey...
... that is home to one-third of Canadians. The healt... endangering health of children in Ontario.// Chil...osed to high doses of radiation. Children were exp... Opposition leaders in the province have criticiz...
...ll now help detection of Neurological disorders in...ng any of them//. Melbourne researchers have ...ious smells such as coffee, whisky, roses and blea...iatry Clinic, Christos Pantelis said, "The test ha...
...me that is known to have healing properties. It wa...ism and the amount of telomerase expressed were// ...elomerase is also known to increase the rate of ca...imals express telomerase while others, like humans...
Other Medicine News:Health News:Study Uncovers Mutation Responsible for Noonan Syndrome 2Health News:Detection of Neurological Disorder is Just a Sniff Away!! 2Health News:Telomerase Expression Linked To Body Mass 2Health News:Telomerase Expression Linked To Body Mass 3
(Date:11/20/2009)...ov. 20 Biotel Inc. (OTC ...rst quarter ended September 30, 2009 with net earn...evenues of $3,263,000. This compares to net earni...venues of $3,168,000 for the first quarter of last...ts, Biotel President and CEO Steve Springrose said...
(Date:11/20/2009)...S, N.J., Nov. 20 BD (Bec...nnounced the completion of its acquisition of Hand...hat develops and manufactures molecular diagnostic...9, BD and HandyLab announced an exclusive agreemen...says on the HandyLab Jaguar(TM) platform, the firs...
(Date:11/19/2009)...nd, Nov. 19 Warner Chilcott plc (N...previously announced secondary offering of 20,000,...c of $22.25 per share. The selling shareholders i..., DLJ Merchant Banking, J.P. Morgan Partners (advi....P., certain other institutional investors and mem...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Tampa Bay Doctor Agrees to Pay United States 241 7 Million to Resolve Medicare Fraud Allegations 52025 1Tampa Bay Doctor Agrees to Pay United States 241 7 Million to Resolve Medicare Fraud Allegations 52025 2American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 1American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 2American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 3American Health Assistance Foundation 26 Asbury Methodist Village to Host Special Community Screenings and Discussion of HBO Series The Alzheimers Pr 52020 4Addus HomeCare Corporation Files Registration Statement 52015 1Addus HomeCare Corporation Files Registration Statement 52015 2
...ass Biologic Treatment Option Now Available for ...) -, PRINCETON, N.J., April 8, 2008 Bristol-Myer...t the U.S. Food and Drug,Administration (FDA) has ...,and symptoms in pediatric patients six years and ...ular juvenile idiopathic arthritis (JIA). ORENCIA,...
...008 ImQuest scientists Robert,W. Buckheit, Jr., P...ts of,studies performed with products licensed by ...ides 2008, an international conference held in New...ts, developers, and care,givers from around the wo...erence organizers, presenting the results of ImQue...
Other Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India 2
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: